NCT04623047View on ClinicalTrials.gov

Infection Watch Study

CompletedOBSERVATIONAL
Enrollment

10,034

Participants

Timeline

Start Date

June 28, 2023

Primary Completion Date

June 15, 2024

Study Completion Date

June 15, 2024

Conditions
COVID-19 Respiratory InfectionRespiratory Syncytial Virus InfectionsRhinoviral InfectionsInfluenza Viral Infections
Trial Locations (1)

27705

Duke University, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Duke University

OTHER

NCT04623047 - Infection Watch Study | Biotech Hunter | Biotech Hunter